Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving T2DM Detection Among At-Risk Individuals - Effectiveness of Active Opportunistic Screening Using Spot Capillary-HbA1c Test - a Cluster Randomized Controlled Trial (DM-REACH)

NCT06382363 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT06382363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06382363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving T2DM Detection Among At-Risk Individuals - Effectiveness of Active Opportunistic Screening Using Spot Capillary-HbA1c Test - a Cluster Randomized Controlled Trial (DM-REACH)
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
June 11, 2022
Completion date
December 12, 2023
Enrollment
852 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, pre-diabetes